Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-11-002234
Filing Date
2011-03-16
Accepted
2011-03-16 17:16:10
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2202710z10-k.htm 10-K 915248
2 EX-4.6 a2202710zex-4_6.htm EX-4.6 35256
3 EX-10.7 a2202710zex-10_7.htm EX-10.7 101331
4 EX-23 a2202710zex-23.htm EX-23 3023
5 EX-31.1 a2202710zex-31_1.htm EX-31.1 7681
6 EX-31.2 a2202710zex-31_2.htm EX-31.2 7706
7 EX-32.1 a2202710zex-32_1.htm EX-32.1 4088
8 EX-32.2 a2202710zex-32_2.htm EX-32.2 4108
  Complete submission text file 0001047469-11-002234.txt   1079670
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-131722 | Film No.: 11692783
SIC: 2834 Pharmaceutical Preparations